The Meniere’s Disease and Cialis Connection

Hearing & Brain Health

In general, some side effects may be more likely to occur or may be slightly worse with higher doses of Cialis. Talk with your doctor or pharmacist if you have additional questions about how long Cialis side effects can last. If you develop serious side effects while taking Cialis, call your doctor right away. If the side effects seem life threatening or you think you’re having a medical emergency, immediately call 911 or your local emergency number. The list below may not include all possible serious side effects of the drug. Percentage of patients reporting at least one attack in the previous 6 months, according to the number of CVRFs.

When the latest iPad or iPhone is used, the high-speed image processing system enables us to instantly analyze the autonomic function of sympathetic and parasympathetic nerves without using any drugs. Furthermore, results can be obtained in real time, which greatly reduces the burden on patients. Problems with methacholine have recently been found, and therefore, this drug is currently not used for clinical studies of autonomic nervous function.

Corticosteroids have been shown to have a lower risk of hearing damage [15,16] but less efficacy in vertigo attack control compared to gentamicin [17,18]. No, but if you have Ménière’s disease, you can reduce your risk the disease will worsen. Contact your healthcare provider if you suddenly develop dizzy spells that may be vertigo.

Meniere’s disease is a condition that affects the inner ear, causing symptoms such as vertigo, hearing loss, tinnitus, and a feeling of fullness in the ear. It can be a debilitating condition that significantly impacts a person’s quality of life.

What is Cialis?

A determinant of EBV-infection was specified within the methodology of five of fourteen studies, and three of those presented data that was adequate for pooling. Under the DL τ2 estimator (logOR (95% C.I.)), the overall effect size was 1.70 (0.50–5.81), and thus not significant. Higgin’s I2 was not substantial (0.00%), nor was Cochran’s Q significant. For the OR obtained in each study down the page is represented by the confidence interval across the page, and the exact values corresponding to the interval are presented on the RHS. The overall effects obtained by pooled REML and DL inverse-variance estimators respectively are indicated by the solid black diamonds at the bottommost part of the figure, with the respective Cochran’s Q and Higgin’s I2 heterogeneity statistics presented alongside. For the purposes of meta-analysis, we also used the “metafor” and “metaviz” extensions for R (see [42] for “metafor”; see [43] for “metaviz”).

The main CVRF was hypertension (42%) followed by excessive BMI (20%) and dyslipidaemia (20%). Mean PTA threshold was 60.3 dB (±23.3 dB) and median value of SDT was 79.6% (±25.6%) (Table 2). Caloric stimulation tests were performed in 48.4% of patients and were pathological in 100% of these. The mean value of vestibular function percentage loss was 54% (±22.5%) (Table 2). According to self-reported data, mean MD course disease was 7.7 years (±5.6 years) (Table 2).

These findings point to a possible influence of the CVRFs over the course and severity of the disease. Indeed, according to our results, our MD population, when excluding potential aetiological factors, such as allergy/atopy, auto-immune disease and migraine, seem to have a high overall cardiovascular risk, especially due to hypertension. They found that elderly subjects presented a more “aggressive” evolution of MD and hypothesized that vascular disorders could act as a predisposing factor for MD (R. Teggi et al., 2012). Frejo et al., in 2016, studying clinical phenotypes in bilateral MD also found a group defined by synchronic hearing loss without migraine or auto-immune disease with a vascular risk profile which did not overlap with the other 4 phenotypes described. These authors recommend further studies to assess the role of inner ear microvasculature circulation in MD (Frejo et al., 2016).

Cialis is a medication commonly used to treat erectile dysfunction (ED) in men. It works by increasing blood flow to the penis, allowing for a stronger and longer-lasting erection. However, Cialis is also sometimes prescribed to treat symptoms of benign prostatic hyperplasia (BPH), a condition that affects the prostate gland.

The Connection:

Recent studies have suggested a potential connection between Meniere’s disease and the use of Cialis. Some patients with Meniere’s disease who were also taking Cialis reported an exacerbation of their symptoms, particularly increased episodes of vertigo.

FAQs about the Meniere’s Disease and Cialis Connection:

  • Can Cialis cause or worsen Meniere’s disease symptoms?
  • While more research is needed to fully understand the connection, some patients have reported a worsening of their Meniere’s disease symptoms while taking Cialis.

  • Should individuals with Meniere’s disease avoid taking Cialis?
  • It is important for individuals with Meniere’s disease to consult with their healthcare provider before taking Cialis or any other medications, to discuss potential risks and benefits.

In conclusion, while the connection between Meniere’s disease and Cialis is still being studied, it is important for individuals with Meniere’s disease to be aware of how certain medications may impact their symptoms. Consulting with a healthcare provider is crucial in determining the best course of treatment for both Meniere’s disease and any other conditions a person may have.

Scroll to Top